123 results on '"Asante-Poku, Adwoa"'
Search Results
2. Viewpoint of multi-omics potential in tuberculosis research: identifying biomarkers for biomanufacturing of efficient control tools.
- Author
-
Otchere, Isaac Darko, Aboagye, Sammy Yaw, Arthur, Patrick Kobina, and Asante-Poku, Adwoa
- Published
- 2024
- Full Text
- View/download PDF
3. Molecular epidemiology and drug susceptibility profiles of Mycobacterium tuberculosis complex isolates from Northern Ghana
- Author
-
Acquah, Samuel Kobina Ekuban, Asare, Prince, Osei-Wusu, Stephen, Morgan, Portia, Afum, Theophilus, Asandem, Diana Asema, Danso, Emelia Konadu, Otchere, Isaac Darko, Ofori, Linda Aurelia, Obiri-Danso, Kwasi, Kock, Richard, Asante-Poku, Adwoa, and Yeboah-Manu, Dorothy
- Published
- 2021
- Full Text
- View/download PDF
4. Genomic epidemiological analysis identifies high relapse among individuals with recurring tuberculosis and provides evidence of recent household-related transmission of tuberculosis in Ghana
- Author
-
Asare, Prince, Osei-Wusu, Stephen, Baddoo, Nyonuku Akosua, Bedeley, Edmund, Otchere, Isaac Darko, Brites, Daniela, Loiseau, Chloé, Asante-Poku, Adwoa, Prah, Diana Ahu, Borrell, Sonia, Reinhard, Miriam, Omari, Michael Amo, Forson, Audrey, Koram, Kwadwo Ansah, Gagneux, Sebastien, and Yeboah-Manu, Dorothy
- Published
- 2021
- Full Text
- View/download PDF
5. Opinion review of drug resistant tuberculosis in West Africa: tackling the challenges for effective control.
- Author
-
Otchere, Isaac Darko, Asante-Poku, Adwoa, Akpadja, Kodjo Francis, Diallo, Awa Ba, Sanou, Adama, Asare, Prince, Osei-Wusu, Stephen, Onyejepu, Nneka, Diarra, Bassirou, Dagnra, Yaotsè Anoumou, Kehinde, Aderemi, Antonio, Martin, and Yeboah-Manu, Dorothy
- Published
- 2024
- Full Text
- View/download PDF
6. Reduced transmission of Mycobacterium africanum compared to Mycobacterium tuberculosis in urban West Africa
- Author
-
Asare, Prince, Asante-Poku, Adwoa, Prah, Diana Ahu, Borrell, Sonia, Osei-Wusu, Stephen, Otchere, Isaac Darko, Forson, Audrey, Adjapong, Gloria, Koram, Kwadwo Ansah, Gagneux, Sebastien, and Yeboah-Manu, Dorothy
- Published
- 2018
- Full Text
- View/download PDF
7. Learning from epidemiological, clinical, and immunological studies on Mycobacterium africanum for improving current understanding of host–pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies, and vaccines for tuberculosis
- Author
-
Zumla, Alimuddin, Otchere, Isaac Darko, Mensah, Gloria Ivy, Asante-Poku, Adwoa, Gehre, Florian, Maeurer, Markus, Bates, Matthew, Mwaba, Peter, Ntoumi, Francine, and Yeboah-Manu, Dorothy
- Published
- 2017
- Full Text
- View/download PDF
8. Macrophage susceptibility to infection by Ghanaian Mycobacterium tuberculosis complex lineages 4 and 5 varies with self-reported ethnicity.
- Author
-
Osei-Wusu, Stephen, Tetteh, John K. A., Musah, Abdul Basit, Ntiamoah, Desmond Opoku, Arthur, Nelly, Adjei, Abraham, Arbues, Ainhoa, Ofori, Ebenezer Addo, Mensah, Kwadwo Akyea, Afua Galevo, Sutaya Elsie, Frempong, Abena Frema, Asare, Prince, Asante-Poku, Adwoa, Otchere, Isaac Darko, Kusi, Kwadwo Asamoah, Lenz, Tobias L., Gagneux, Sebastien, Portevin, Damien, and Yeboah-Manu, Dorothy
- Subjects
MYCOBACTERIUM tuberculosis ,MYCOBACTERIAL diseases ,MONONUCLEAR leukocytes ,MACROPHAGES ,ETHNICITY ,PITUITARY dwarfism ,PHAGOCYTOSIS - Abstract
Background: The epidemiology of Mycobacterium tuberculosis complex (MTBC) lineage 5 (L5) infections in Ghana revealed a significantly increased prevalence in Ewes compared to other self-reported ethnic groups. In that context, we sought to investigate the early phase of tuberculosis (TB) infection using ex vivo infection of macrophages derived from the blood of Ewe and Akan ethnic group volunteers with MTBC L4 and L5 strains. Methods: The study participants consisted of 16 controls, among which self-reported Akan and Ewe ethnicity was equally represented, as well as 20 cured TB cases consisting of 11 Akans and 9 Ewes. Peripheral blood mononuclear cells were isolated from both healthy controls and cured TB cases. CD14
+ monocytes were isolated and differentiated into monocyte-derived macrophages (MDMs) before infection with L4 or L5 endemic strains. The bacterial load was assessed after 2 hours (uptake) as well as 3 and 7 days post-infection. Results: We observed a higher capacity of MDMs from Ewes to phagocytose L4 strains (p < 0.001), translating into a higher bacillary load on day 7 (p < 0.001) compared to L5, despite the higher replication rate of L5 in Ewe MDMs (fold change: 1.4 vs. 1.2, p = 0.03) among the controls. On the contrary, within macrophages from Akans, we observed a significantly higher phagocytic uptake of L5 (p < 0.001) compared to L4, also translating into a higher load on day 7 (p = 0.04). However, the replication rate of L4 in Akan MDMs was higher than that of L5 (fold change: L4 = 1.2, L4 = 1.1, p = 0.04). Although there was no significant difference in the uptake of L4 and L5 among cured TB cases, there was a higher bacterial load of both L4 (p = 0.02) and L5 (p = 0.02) on day 7 in Ewe MDMs. Conclusion: Our results suggest that host ethnicity (driven by host genetic diversity), MTBC genetic diversity, and individual TB infection history are all acting together to modulate the outcome of macrophage infections by MTBC. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
9. Evaluation of a loop-mediated amplification test for rapid diagnosis of tuberculosis in Ghana
- Author
-
Otchere, Isaac D, Afum, Theophilus, Morgan, Portia, Musah, Abdul B, YAboagye, Sammy, Asare, Prince, Osei-Wusu, Stephen, Yirenkye, Stephen O, Tetteh-Ocloo, Georgina, Ansa, Gloria, Laryea, Clement, Forson, Audrey, Asante-Poku, Adwoa, and Yeboah-Manu, Dorothy
- Subjects
Mycobacterium tuberculosis, loop-mediated amplification, isothermal, diagnostics, Ghana - Abstract
Background: The unavailability of cheap but rapid, highly sensitive and specific diagnostic tools for tuberculosis (TB) remains a major setback for the global efforts to end TB by the year 2035. Nucleic acid-based TB diagnostic assays remain the most recommended and the Gene Xpert MTB/RIF (Cepheid Sunnyvale, United States) is the most widely used which has an added advantage of detecting rifampicin resistance. However, the machinery requirement of the GeneXpert MTB/RIF makes it unsuitable for use in rural and resource-limited settings eventually challenging the global efforts to end TB by the year 2035. Loop-mediated amplification (LAMP) of DNA technology presents a cheap alternative for the precision diagnosis of TB.Objective: In this study, we evaluated the specificity and sensitivity of the TB-LAMP assay kit manufactured by Human Diagnostics Worldwide (Geneva, Switzerland) for the diagnosis of TB in Ghana. Methods: We assessed the performance of the TB-LAMP assay against a panel of genotyped mycobacteria (including members of the Mycobacterium tuberculosis complex (MTBC) and a couple of nontuberculous mycobacteria) and sputum samples collected from presumptive TB patients using sputum culture as reference diagnostic assay.Results: The TB-LAMP assay was found to be very specific in detecting members of the MTBC as positive samples whereas the nontuberculous mycobacteria were all negative. Using sputum culture as a reference, the TB-LAMP assay was found to have 99.2% sensitivity, 97.2% specificity, 98.5% positive predictive value (PPV), 98.6% negative predictive value (NPV) and 98.5% accuracy for detection of MTBC among sputum samples collected from presumptive TB patients in Ghana. The TB-LAMP assay additionally showed 100% accuracy in detecting members of the MTBC among a panel of mycobacteria.Conclusion: The TB-LAMP is highly sensitive and specific for the diagnosis of TB. It is thence recommended for use as a primary screening tool before referral for culture and sensitivity assays for better management of TB.
- Published
- 2022
10. Comparative genomics of Mycobacterium africanum Lineage 5 and Lineage 6 from Ghana suggests distinct ecological niches
- Author
-
Otchere, Isaac Darko, Coscollá, Mireia, Sánchez-Busó, Leonor, Asante-Poku, Adwoa, Brites, Daniela, Loiseau, Chloe, Meehan, Conor, Osei-Wusu, Stephen, Forson, Audrey, Laryea, Clement, Yahayah, Abdallah Iddrisu, Baddoo, Akosua, Ansa, Gloria Akosua, Aboagye, Samuel Yaw, Asare, Prince, Borrell, Sonia, Gehre, Florian, Beckert, Patrick, Kohl, Thomas A., N’dira, Sanoussi, Beisel, Christian, Antonio, Martin, Niemann, Stefan, de Jong, Bouke C., Parkhill, Julian, Harris, Simon R., Gagneux, Sebastien, and Yeboah-Manu, Dorothy
- Published
- 2018
- Full Text
- View/download PDF
11. Gut microbiome variation in pulmonary TB patients with diabetes or HIV comorbidities.
- Author
-
Morgan, Portia Abena, Parbie, Prince Kofi, Ntiamoah, Desmond Opoku, Boadu, Augustine Asare, Asare, Prince, Lamptey, Ivy Naa Koshie, Gorman, Cecilia Nancy, Afreh, Emmanuel, Asante-Poku, Adwoa, Otchere, Isaac Darko, Aboagye, Sammy Yaw, and Yeboah-Manu, Dorothy
- Subjects
GUT microbiome ,COMMUNICABLE diseases ,TUBERCULOSIS ,PEOPLE with diabetes ,COMORBIDITY ,SHIGELLOSIS ,NON-communicable diseases - Abstract
Background: The gutmicrobiota is known to play a critical role in shaping the host immunity, and metabolism and influences the onset and progression of both communicable and non-communicable diseases. This study assessed the gut microbiome of tuberculosis (TB) cases with diabetes mellitus (DM) or HIV comorbidities before anti-TB therapy and after the intensive phase anti-TB therapy. Methods: Ninety cases comprising 60 TB-only, 23 TB-DM, 7 TB-HIV were recruited, among which 35 TB-only, 10 TB-DM, 5 TB-HIV were also sampled after 2 months of anti-TB treatment. Total gut microbiome was detected by 16S rRNA gene sequencing of DNA extracted from collected stool specimen. The taxonomic and functional diversity of the different groups were compared in addition to changes that could occur after 2 months antibiotics use. Results: Compared to the healthy controls, the gut microbiome of all the TB cohorts was characterized by a significant decreased alpha diversity and significant compositional changes. All the three TB cohorts were enriched with inflammatory related microorganisms of the genera Escherichia-shigella, Streptococcus, Enterococcus and Erysipelatoclostridium with depletion in beneficial taxa of the genera Faecalibacterium, Bifidobacterium and Clostridium. In pairwise comparison with the healthy controls, the TB-only cohort were enriched with Streptococcus and Erysipelatoclostridium, the TBDM enriched with Bacteroides, and TB-HIV enriched with Escherichia-shigella, Dialister and Erysipelatoclostridium. After the intensive phase anti-TB therapy, there was general enrichment of the genera Erysipelotrichaceae_UCG 003, Veillonella and Fusobacterium. Conclusion: Our findings show a dysbiotic gut microbiome and associated upregulation of inflammation related microorganism in gut microbiome of TB individuals with or without comorbidity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases.
- Author
-
Darko Otchere, Isaac, Abena Morgan, Portia, Asare, Prince, Osei-Wusu, Stephen, Yaw Aboagye, Samuel, Ofori Yirenkyi, Stephen, Basit Musah, Abdul, Konadu Danso, Emelia, Tetteh-Ocloo, Georgina, Afum, Theophilus, Asante-Poku, Adwoa, Laryea, Clement, Poku, Yaw Adusi, Bonsu, Frank, Gagneux, Sebastien, and Yeboah-Manu, Dorothy
- Subjects
DRUG resistance ,TUBERCULOSIS patients ,TUBERCULOSIS ,HEALTH facilities ,PATIENT compliance ,LIFE sciences - Abstract
Background: Resistance to tuberculosis (TB) drugs has become a major threat to global control efforts. Early case detection and drug susceptibility profiling of the infecting bacteria are essential for appropriate case management. The objective of this study was to determine the drug susceptibility profiles of difficult-to-treat (DTT) TB patients in Ghana. Methods: Sputum samples obtained from DTT-TB cases from health facilities across Ghana were processed for rapid diagnosis and detection of drug resistance using the Genotype MTBDRplus and Genotype MTBDRsl.v2 from Hain Life science. Results: A total of 298 (90%) out of 331 sputum samples processed gave interpretable bands out of which 175 (58.7%) were resistant to at least one drug (ANY
r ); 16.8% (50/298) were isoniazid-mono-resistant (INHr ), 16.8% (50/298) were rifampicin-mono-resistant (RIFr), and 25.2% (75/298) were MDR. 24 (13.7%) of the ANYr were additionally resistant to at least one second line drug: 7.4% (2 RIFr , 1 INHr , and 10 MDR samples) resistant to only FQs and 2.3% (2 RIFr , 1 INHr , and 1 MDR samples) resistant to AMG drugs kanamycin (KAN), amikacin (AMK), capreomycin (CAP), and viomycin (VIO). Additionally, there were 4.0% (5 RIFr and 2 MDR samples) resistant to both FQs and AMGs. 81 (65.6%) out of 125 INH-resistant samples including INHr and MDR had katG-mutations (MT) whereas 15 (12%) had inhApro-MT. The remaining 28 (22.4%) had both katG and inhA MT. All the 19 FQ-resistant samples were gyrA mutants whereas the 10 AMGs were rrs (3), eis (3) as well as rrs, and eis co-mutants (4). Except for the seven pre-XDR samples, no sample had eis MT. Conclusion: The detection of several pre-XDR TB cases in Ghana calls for intensified drug resistance surveillance and monitoring of TB patients to, respectively, ensure early diagnosis and treatment compliance. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
13. Molecular epidemiology of bovine tuberculosis in Northern Ghana identifies several uncharacterized bovine spoligotypes and suggests possible zoonotic transmission.
- Author
-
Acquah, Samuel Ekuban Kobina, Asare, Prince, Danso, Emelia Konadu, Tetteh, Phillip, Tetteh, Amanda Yaa, Boateng, Daniel, Osei-Wusu, Stephen, Afum, Theophilus, Ayamdooh, Yolanda Isabel, Akugre, Eric Agongo, Samad, Omar Abdul, Quaye, Lawrence, Obiri-Danso, Kwasi, Kock, Richard, Asante-Poku, Adwoa, and Yeboah-Manu, Dorothy
- Subjects
TUBERCULOSIS in cattle ,MOLECULAR epidemiology ,MYCOPLASMA bovis ,MYCOBACTERIA ,ORGAN culture ,BOS ,MYCOBACTERIUM bovis ,FOOT & mouth disease - Abstract
Objective: We conducted an abattoir-based cross-sectional study in the five administrative regions of Northern Ghana to determine the distribution of bovine tuberculosis (BTB) among slaughtered carcasses and identify the possibility of zoonotic transmission. Methods: Direct smear microscopy was done on 438 tuberculosis-like lesions from selected cattle organs and cultured on Lowenstein-Jensen media. Acid-fast bacilli (AFB) isolates were confirmed as members of the Mycobacterium tuberculosis complex (MTBC) by PCR amplification of IS6110 and rpoß. Characterization and assignment into MTBC lineage and sub-lineage were done by spoligotyping, with the aid of the SITVIT2, miruvntrplus and mbovis.org databases. Spoligotype data was compared to that of clinical M. bovis isolates from the same regions to identify similarities. Results: A total of 319/438 (72.8%) lesion homogenates were smear positive out of which, 84.6% (270/319) had microscopic grade of at least 1+ for AFB. Two hundred and sixty-five samples (265/438; 60.5%) were culture positive, of which 212 (80.0%) were MTBC. Approximately 16.7% (34/203) of the isolates with correctly defined spoligotypes were negative for IS6110 PCR but were confirmed by rpoß. Spoligotyping characterized 203 isolates as M. bovis (198, 97.5%), M. caprae (3, 1.5%), M. tuberculosis (Mtbss) lineage (L) 4 Cameroon sub-lineage, (1, 0.5%), and M. africanum (Maf) L6 (1, 0.5%). A total of 53 unique spoligotype patterns were identified across the five administrative regions (33 and 28 were identified as orphan respectively by the SITVIT2 and mbovis.org databases), with the most dominant spoligotype being SIT1037/ SB0944 (77/203, 37.93%). Analysis of the bovine and human M. bovis isolates showed 75% (3/4) human M. bovis isolates sharing the same spoligotype pattern with the bovine isolates. Conclusion: Our study identified that approximately 29% of M. bovis strains causing BTB in Northern Ghana are caused by uncharacterized spoligotypes. Our findings suggest possible zoonotic transmission and highlight the need for BTB disease control in Northern Ghana. Author summary: Bovine tuberculosis (BTB) is a disease of global public and animal health significance. The disease is endemic in major livestock producing countries in sub-Saharan Africa. Little or no attention is given to the disease and its impact on livestock and humans. We conducted a cross sectional molecular epidemiology study in Northern Ghana to understand the population structure and distribution of tuberculosis in cattle and to assess the possibility of transmission of the disease to humans. We collected tuberculosis-like lesions from selected cattle organs from three regional abattoirs in the five administrative regions of Northern Ghana and found half of the total samples to be infected with Mycobacterium bovis. Majority of our isolates appeared to be uncharacterised suggesting the need for routine tracking and characterisation of the M. bovis species circulating in the sub-region. Comparison of our analysis of the M. bovis from bovine origin to that obtained from human M. bovis from the same geographical area showed 75% (3/4) of the human M. bovis isolates having same molecular pattern with the bovine isolates. Our findings suggest possible zoonotic transmission and highlight the need for BTB disease control in Northern Ghana. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Diarrhea-Causing Bacteria and Their Antibiotic Resistance Patterns Among Diarrhea Patients From Ghana.
- Author
-
Afum, Theophilus, Asandem, Diana Asema, Asare, Prince, Asante-Poku, Adwoa, Mensah, Gloria Ivy, Musah, Abdul Basit, Opare, David, Taniguchi, Kiyosi, Guinko, Nuhu Muniru, Aphour, Thelma, Arhin, Doris, Ishikawa, Koichi, Matano, Tetsuro, Mizutani, Taketoshi, Asiedu-Bekoe, Franklin, Kiyono, Hiroshi, Anang, Abraham Kwabena, Koram, Kwadwo Ansah, and Yeboah-Manu, Dorothy
- Subjects
AMIKACIN ,DRUG resistance in bacteria ,VIBRIO parahaemolyticus ,BACTERIA ,ESCHERICHIA coli ,HEALTH facilities ,ANTIBIOTICS ,SALMONELLA - Abstract
Diarrheal disease remains a major global health problem particularly in children under 5 years and the emergence of antibiotic-resistant strains of causative pathogens could slow control efforts, particularly in settings where treatment options are limited. This surveillance study conducted in Ghana aimed to determine the prevalence and antimicrobial susceptibility profile of diarrhea-causing bacteria. This was a cross-sectional study carried out in five health facilities in the Ga West Municipality of Ghana between 2017 and 2021. Diarrheic stool samples from patients were collected and cultured on standard differential/selective media and isolates identified by standard biochemical tests, MALDI-TOF assay, and serological analysis. The antibiogram was determined using Kirby-Bauer disk diffusion and Microscan autoScan4 MIC panels which were used for extended-spectrum beta-lactamase (ESBL) detection. Bacteria were isolated from 97.5% (772/792) of stool samples, and 167 of the isolates were diarrheagenic and met our inclusion criteria for antimicrobial resistance (AMR) analysis. These included Escherichia coli (49.1%, 82/167), Salmonella species (23.9%, 40/167), Vibrio species (16.8%, 28/167), and Shigella species (10.2%, 17/167). Among 24 Vibrio species, we observed resistances to cefotaxime (21/24, 87.5%), ceftriaxone (20/24, 83.3%), and ciprofloxacin (6/24, 25%), including four multi-drug resistant isolates. All 13 Vibrio parahaemolyticus isolates were resistant to cefazolin. All 17 Shigella isolates were resistant to tetracycline with resistance to shigellosis drugs such as norfloxacin and ciprofloxacin. Salmonella isolates were highly susceptible to norfloxacin (40/40, 100%) and tetracycline (12/34, 35%). Two ESBL-producing E. coli were also identified with marked susceptibility to gentamicin (66/72, 91.7%) and amikacin (57/72, 79.2%) prescribed in the treatment of E. coli infections. This study showed the different bacteria implicated in diarrhea cases in Ghana and the need for differential diagnoses for better treatment outcomes. Escherichia coli , Shigella , Salmonella , and Vibrio have all been implicated in diarrhea cases in Ghana. The highest prevalence was E. coli and Salmonella with Shigella the least prevalent. Resistance to commonly used drugs found in these isolates may render bacteria infection treatment in the near future nearly impossible. Routine antimicrobial susceptibility testing, effective monitoring, and nationwide surveillance of AMR pathogens should be implemented to curb the increase of antimicrobial resistance in Ghana. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Genetic Analysis of TB Susceptibility Variants in Ghana Reveals Candidate Protective Loci in SORBS2 and SCL11A1 Genes.
- Author
-
Asante-Poku, Adwoa, Morgan, Portia, Osei-Wusu, Stephen, Aboagye, Samuel Yaw, Asare, Prince, Otchere, Isaac Darko, Adadey, Samuel Mawuli, Mnika, Khuthala, Esoh, Kevin, Mawuta, Kenneth Hayibor, Arthur, Nelly, Forson, Audrey, Mazandu, Gaston Kuzamunu, Wonkam, Ambroise, and Yeboah-Manu, Dorothy
- Subjects
TUBERCULOSIS ,MYCOBACTERIUM tuberculosis ,LOCUS (Genetics) ,PUBLIC health ,GENES ,GENE frequency - Abstract
Despite advancements made toward diagnostics, tuberculosis caused by Mycobacterium africanum (Maf) and Mycobacterium tuberculosis sensu stricto (Mtbss) remains a major public health issue. Human host factors are key players in tuberculosis (TB) outcomes and treatment. Research is required to probe the interplay between host and bacterial genomes. Here, we explored the association between selected human/host genomic variants and TB disease in Ghana. Paired host genotype datum and infecting bacterial isolate information were analyzed for associations using a multinomial logistic regression. Mycobacterium tuberculosis complex (MTBC) isolates were obtained from 191 TB patients and genotyped into different phylogenetic lineages by standard methods. Two hundred and thirty-five (235) nondisease participants were used as healthy controls. A selection of 29 SNPs from TB disease-associated genes with high frequency among African populations was assayed using a TaqMan® SNP Genotyping Assay and iPLEX Gold Sequenom Mass Genotyping Array. Using 26 high-quality SNPs across 326 case-control samples in an association analysis, we found a protective variant, rs955263, in the SORBS2 gene against both Maf and Mtb infections (P
BH = 0.05; OR = 0.33; 95% CI = 0.32–0.34). A relatively uncommon variant, rs17235409 in the SLC11A1 gene was observed with an even stronger protective effect against Mtb infection (MAF = 0.06; PBH = 0.04; OR = 0.05; 95% CI = 0.04–0.05). These findings suggest SLC11A1 and SORBS2 as a potential protective gene of substantial interest for TB, which is an important pathogen in West Africa, and highlight the need for in-depth host-pathogen studies in West Africa. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
16. Diagnosis of tuberculosis among COVID-19 suspected cases in Ghana.
- Author
-
Afum, Theophilus, Asare, Prince, Asante-Poku, Adwoa, Darko-Otchere, Isaac, Morgan, Portia Abena, Bedeley, Edmund, Asandem, Diana Asema, Musah, Abdul Basit, Siam, Ishaque Mintah, Tetteh, Phillip, Adusi-Poku, Yaw, Frimpong-Manso, Rita, Bonney, Joseph Humphrey Kofi, Ampofo, William, and Yeboah-Manu, Dorothy
- Subjects
TUBERCULOSIS ,COVID-19 pandemic ,AIRBORNE infection ,MYCOBACTERIUM tuberculosis ,RESPIRATORY organs ,DIAGNOSIS - Abstract
Background: Tuberculosis (TB) and COVID-19 pandemics are both diseases of public health threat globally. Both diseases are caused by pathogens that infect mainly the respiratory system, and are involved in airborne transmission; they also share some clinical signs and symptoms. We, therefore, took advantage of collected sputum samples at the early stage of COVID-19 outbreak in Ghana to conduct differential diagnoses of long-standing endemic respiratory illness, particularly tuberculosis. Methodology: Sputum samples collected through the enhanced national surveys from suspected COVID-19 patients and contact tracing cases were analyzed for TB. The sputum samples were processed using Cepheid's GeneXpert MTB/RIF assay in pools of 4 samples to determine the presence of Mycobacterium tuberculosis complex. Positive pools were then decoupled and analyzed individually. Details of positive TB samples were forwarded to the NTP for appropriate case management. Results: Seven-hundred and seventy-four sputum samples were analyzed for Mycobacterium tuberculosis in both suspected COVID-19 cases (679/774, 87.7%) and their contacts (95/774, 12.3%). A total of 111 (14.3%) were diagnosed with SARS CoV-2 infection and six (0.8%) out of the 774 individuals tested positive for pulmonary tuberculosis: five (83.3%) males and one female (16.7%). Drug susceptibility analysis identified 1 (16.7%) rifampicin-resistant tuberculosis case. Out of the six TB positive cases, 2 (33.3%) tested positive for COVID-19 indicating a coinfection. Stratifying by demography, three out of the six (50%) were from the Ayawaso West District. All positive cases received appropriate treatment at the respective sub-district according to the national guidelines. Conclusion: Our findings highlight the need for differential diagnosis among COVID-19 suspected cases and regular active TB surveillance in TB endemic settings. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
17. Surveillance for peri-elimination trachoma recrudescence: Exploratory studies in Ghana.
- Author
-
Senyonjo, Laura, Addy, James, Martin, Diana L., Agyemang, David, Yeboah-Manu, Dorothy, Gwyn, Sarah, Marfo, Benjamin, Asante-Poku, Adwoa, Aboe, Agatha, Solomon, Anthony W., and Bailey, Robin L.
- Subjects
TRACHOMA ,CHLAMYDIA trachomatis ,GOAL programming ,SEROPREVALENCE ,DRIED blood spot testing - Abstract
Introduction: To date, eleven countries have been validated as having eliminated trachoma as a public health problem, including Ghana in 2018. Surveillance for recrudescence is needed both pre- and post-validation but evidence-based guidance on appropriate strategies is lacking. We explored two potential surveillance strategies in Ghana. Methodology/principal findings: Amongst randomly-selected communities enrolled in pre-validation on-going surveillance between 2011 and 2015, eight were identified as having had trachomatous-inflammation follicular (TF) prevalence ≥5% in children aged 1–9 years between 2012 and 2014. These eight were re-visited in 2015 and 2016 and neighbouring communities were also added ("TF trigger" investigations). Resident children aged 1–9 years were then examined for trachoma and had a conjunctival swab to test for Chlamydia trachomatis (Ct) and a dried blood spot (DBS) taken to test for anti-Pgp3 antibodies. These investigations identified at least one community with evidence of probable recent Ct ocular transmission. However, the approach likely lacks sufficient spatio-temporal power to be reliable. A post-validation surveillance strategy was also evaluated, this reviewed the ocular Ct infection and anti-Pgp3 seroprevalence data from the TF trigger investigations and from the pre-validation surveillance surveys in 2015 and 2016. Three communities identified as having ocular Ct infection >0% and anti-Pgp3 seroprevalence ≥15.0% were identified, and along with three linked communities, were followed-up as part of the surveillance strategy. An additional three communities with a seroprevalence ≥25.0% but no Ct infection were also followed up ("antibody and infection trigger" investigations). DBS were taken from all residents aged ≥1 year and ocular swabs from all children aged 1–9 years. There was evidence of transmission in the group of communities visited in one district (Zabzugu-Tatale). There was no or little evidence of continued transmission in other districts, suggesting previous infection identified was transient or potentially not true ocular Ct infection. Conclusions/significance: There is evidence of heterogeneity in Ct transmission dynamics in northern Ghana, even 10 years after wide-scale MDA has stopped. There is added value in monitoring Ct infection and anti-Ct antibodies, using these indicators to interrogate past or present surveillance strategies. This can result in a deeper understanding of transmission dynamics and inform new post-validation surveillance strategies. Opportunities should be explored for integrating PCR and serological-based markers into surveys conducted in trachoma elimination settings. Author summary: The goal for trachoma programmes is elimination of trachoma as a public health problem. This means that ongoing low-level eye-to-eye transmission of the causative bacterium, Chlamydia trachomatis (Ct), is acceptable. Countries need to implement a suitable surveillance system to identify any return to higher transmission levels. The best methodology for doing this is not known. We first explored the approach used by Ghana in its standard programme, which involved monitoring a limited number of randomly selected communities for evidence of active (inflammatory) trachoma visible in children's eyes on examination by trained observers. Although this strategy led to identification of at least one community that had probably had recent Ct transmission, the approach is unlikely to consistently identify places where return to higher levels of transmission is a risk. We also explored using information on infection (detected in eye swabs) and antibodies to Ct (detected in the blood) to identify communities at risk. We found evidence of both persistent eye-to-eye Ct transmission and areas where infection was transient and has now gone away. We conclude that the use of infection and antibody data for surveillance of trachoma appears promising. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
18. Genotypic and phenotypic diversity of Mycobacterium tuberculosis complex genotypes prevalent in West Africa.
- Author
-
Osei-Wusu, Stephen, Otchere, Isaac Darko, Morgan, Portia, Musah, Abdul Basit, Siam, Ishaque Mintah, Asandem, Diana, Afum, Theophilus, Asare, Prince, Asante-Poku, Adwoa, Kusi, Kwadwo Asamoah, Gagneux, Sebastien, and Yeboah-Manu, Dorothy
- Subjects
GENOTYPES ,PHENOTYPES ,MYCOBACTERIUM tuberculosis ,GENOMICS ,PYRUVATES ,COMPARATIVE genomics - Abstract
Findings from previous comparative genomics studies of the Mycobacterium tuberculosis complex (MTBC) suggest genomic variation among the genotypes may have phenotypic implications. We investigated the diversity in the phenotypic profiles of the main prevalent MTBC genotypes in West Africa. Thirty-six whole genome sequenced drug susceptible MTBC isolates belonging to lineages 4, 5 and 6 were included in this study. The isolates were phenotypically characterized for urease activity, tween hydrolysis, Thiophen-2-Carboxylic Acid Hydrazide (TCH) susceptibility, nitric oxide production, and growth rate in both liquid (7H9) and solid media (7H11 and Löwenstein–Jensen (L-J)). Lineage 4 isolates showed the highest growth rate in both liquid (p = 0.0003) and on solid (L-J) media supplemented with glycerol (p<0.001) or pyruvate (p = 0.005). L6 isolates optimally utilized pyruvate compared to glycerol (p<0.001), whereas L5 isolates grew similarly on both media (p = 0.05). Lineage 4 isolates showed the lowest average time to positivity (TTP) (p = 0.01; Average TTP: L4 = 15days, L5 = 16.7days, L6 = 29.7days) and the highest logCFU/mL (p = 0.04; average logCFU/mL L4 = 5.9, L5 = 5.0, L6 = 4.4) on 7H11 supplemented with glycerol, but there was no significant difference in growth on 7H11 supplemented with pyruvate (p = 0.23). The highest release of nitrite was recorded for L5 isolates, followed by L4 and L6 isolates. However, the reverse was observed in the urease activity for the lineages. All isolates tested were resistant to TCH except for one L6 isolate. Comparative genomic analyses revealed several mutations that might explain the diverse phenotypic profiles of these isolates. Our findings showed significant phenotypic diversity among the MTBC lineages used for this study. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. Gut microbiota signature of pathogen-dependent dysbiosis in viral gastroenteritis.
- Author
-
Mizutani, Taketoshi, Aboagye, Samuel Yaw, Ishizaka, Aya, Afum, Theophillus, Mensah, Gloria Ivy, Asante-Poku, Adwoa, Asandem, Diana Asema, Parbie, Prince Kofi, Abana, Christopher Zaab-Yen, Kushitor, Dennis, Bonney, Evelyn Yayra, Adachi, Motoi, Hori, Hiroki, Ishikawa, Koichi, Matano, Tetsuro, Taniguchi, Kiyosu, Opare, David, Arhin, Doris, Asiedu-Bekoe, Franklin, and Ampofo, William Kwabena
- Subjects
GUT microbiome ,VIRAL gastroenteritis ,CARBOHYDRATE metabolism ,ROTAVIRUS diseases ,DIAGNOSIS of diarrhea ,RIBOSOMAL RNA ,DYSBIOSIS - Abstract
Acute gastroenteritis associated with diarrhea is considered a serious disease in Africa and South Asia. In this study, we examined the trends in the causative pathogens of diarrhea and the corresponding gut microbiota in Ghana using microbiome analysis performed on diarrheic stools via 16S rRNA sequencing. In total, 80 patients with diarrhea and 34 healthy adults as controls, from 2017 to 2018, were enrolled in the study. Among the patients with diarrhea, 39 were norovirus-positive and 18 were rotavirus-positive. The analysis of species richness (Chao1) was lower in patients with diarrhea than that in controls. Beta-diversity analysis revealed significant differences between the two groups. Several diarrhea-related pathogens (e.g., Escherichia-Shigella, Klebsiella and Campylobacter) were detected in patients with diarrhea. Furthermore, co-infection with these pathogens and enteroviruses (e.g., norovirus and rotavirus) was observed in several cases. Levels of both Erysipelotrichaceae and Staphylococcaceae family markedly differed between norovirus-positive and -negative diarrheic stools, and the 10 predicted metabolic pathways, including the carbohydrate metabolism pathway, showed significant differences between rotavirus-positive patients with diarrhea and controls. This comparative study of diarrheal pathogens in Ghana revealed specific trends in the gut microbiota signature associated with diarrhea and that pathogen-dependent dysbiosis occurred in viral gastroenteritis. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
20. Molecular epidemiology of Mycobacterium tuberculosis complex in the Volta Region of Ghana.
- Author
-
Ameke, Selassie, Asare, Prince, Aboagye, Samuel Yaw, Otchere, Isaac Darko, Osei-Wusu, Stephen, Yeboah-Manu, Dorothy, and Asante-Poku, Adwoa
- Subjects
MYCOBACTERIUM tuberculosis ,MOLECULAR epidemiology ,HEAT shock proteins - Abstract
Context: Available molecular epidemiological data from recent studies suggest significant genetic variation between the different lineages of Mycobacterium tuberculosis complex (MTBC) and the MTBC lineages might have adapted to different human populations. Aim: This study sought to determine the population structure of clinical MTBC isolates from the Volta Region of Ghana. Methods: The MTBC isolates obtained from collected sputum samples were identified by PCR detecting of IS6110 and genotyped using spoligotyping. Non-tuberculous mycobacterial isolates were characterized by amplification of the heat shock protein 65 (hsp65) gene and sequencing. The drug susceptibility profiles of the MTBCs determined using GenoType MTBDRplus. Results: One hundred and seventeen (117, 93.6%) out of 125 mycobacterial positive isolates were characterized as members of the MTBC of which M. tuberculosis sensu stricto (MTBss) and M. africanum (MAF) were respectively 94 (80.3%) and 23 (19.7%). In all, 39 distinct spoligotype patterns were obtained; 26 for MTBss and 13 for MAF lineages. Spoligotyping identified 89 (76%) Lineage 4, 16 (13.6%) Lineage 5, 7 (6.0%) Lineage 6, 3 (2.6%) Lineage 2, 1(0.9%) Lineage 3 and 1 (0.9%) Lineage 1. Among the Lineage 4 isolates, 62/89 (69.7%) belonged to Cameroon sub-lineage, 13 (14.7%) Ghana, 8 (9.0%) Haarlem, 2 (2.2%) LAM, 1 (1.1%) Uganda I, 1 (1.1%) X and the remaining two (2.2%) were orphan. Significant localization of MAF was found within the Ho municipality (n = 13, 29.5%) compared to the more cosmopolitan Ketu-South/Aflao (n = 3, 8.3%) (p-value = 0.017). Eight (8) non-tuberculous mycobacteria were characterized as M. abscessus (7) and M. fortuitum (1). Conclusion: We confirmed the importance of M. africanum lineages as a cause of TB in the Volta region of Ghana. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. Predictors of Adverse TB Treatment Outcome among TB/HIV Patients Compared with Non-HIV Patients in the Greater Accra Regional Hospital from 2008 to 2016.
- Author
-
Hayibor, Kenneth Mawuta, Bandoh, Delia Akosua, Asante-Poku, Adwoa, and Kenu, Ernest
- Abstract
Introduction. The convergence of TB and HIV dual epidemics is a major public health challenge in Ghana as well as many developing countries. Treatment outcome monitoring is a vital part of the surveillance needed to successfully eliminate TB. The impact of HIV status and demographic and treatment-related factors on adverse TB treatment outcome has not been studied in the Greater Accra Regional Hospital. This study determined factors associated with TB treatment outcome in patients with TB-HIV coinfection and TB-only infection in the hospital. Method. A cross-sectional study was carried out in the Greater Accra Regional Hospital. We reviewed TB treatment cards of patients who received treatment for tuberculosis in the hospital from 2008 to 2016. Data on treatment outcome and sociodemographic and clinical characteristics were extracted on TB-only-infected and TB/HIV-coinfected patients. The chi-squared test and binary and multiple logistic regression models were used to assess factors associated with adverse treatment outcome. Results. Out of the 758 patient records analyzed, 174 (22.9%) were TB-HIV-coinfected patients. Overall treatment success for all TB patients was 88.1% (668/758). About 11.9% (90/758) of the patients had an adverse treatment outcome, including treatment failure 0.9% (7/758), defaulting 0.9% (7/758), and death 10.0% (76/758). TB-HIV-coinfected patients' treatment success was 78.1% (136/174). TB-only patients' treatment success was 91.4% (532/582). Independent predictors of adverse treatment outcome were found to be as follows: being HIV positive (aOR: 3.85, 95% CI: 2.19-6.75; p < 0.01); aged 65 and above (aOR: 1.76, 95% CI: 1.44-1.54; p = 0.01); and previously failed TB treatment (aOR: 5.02, 95% CI: 2.09-28.87; p < 0.01). Conclusion. Treatment outcome for TB-HIV-coinfected patients is below the WHO target. HIV status, age, and category of patient of the TB patients were associated with adverse treatment outcome. Strengthening the TB/HIV collaborative efforts by stakeholders is required for good treatment outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
22. A molecular and epidemiological study of Vibrio cholerae isolates from cholera outbreaks in southern Ghana.
- Author
-
Danso, Emelia Konadu, Asare, Prince, Otchere, Isaac Darko, Akyeh, Lorenzo Moses, Asante-Poku, Adwoa, Aboagye, Samuel Yaw, Osei-Wusu, Stephen, Opare, David, Ntoumi, Francine, Zumla, Alimuddin, Duodu, Samuel, and Yeboah-Manu, Dorothy
- Subjects
VIBRIO cholerae ,CHOLERA ,MICROBIAL sensitivity tests ,CHOLERA toxin ,DRUG resistance in microorganisms ,ENTEROBACTER cloacae ,CLUSTER analysis (Statistics) - Abstract
Cholera remains a major global public health threat and continuous emergence of new Vibrio cholerae strains is of major concern. We conducted a molecular epidemiological study to detect virulence markers and antimicrobial resistance patterns of V. cholerae isolates obtained from the 2012–2015 cholera outbreaks in Ghana. Archived clinical isolates obtained from the 2012, 2014 and 2015 cholera outbreaks in Ghana were revived by culture and subjected to microscopy, biochemical identification, serotyping, antibiotic susceptibility testing, molecular detection of distinct virulence factors and Multi-Locus Variable-Number of Tandem-Repeat Analysis (MLVA). Of 277 isolates analysed, 168 (60.6%) were confirmed to be V. cholerae and 109 (39.4%) isolates constituted other bacteria (Escherichia coli, Aeromonas sobria, Pseudomonas aeruginosa, Enterobacter cloacae and Enterococci faecalis). Serotyping the V. cholerae isolates identified 151 (89.9%) as Ogawa, 3 (1.8%) as Inaba and 14 (8.3%) as non-O1/O139 serogroup. The O1 serogroup isolates (154/168, 91.7%) carried the cholera toxin ctxB gene as detected by PCR. Additional virulence genes detected include zot, tcpA, ace, rtxC, toxR, rtxA, tcpP, hlyA and tagA. The most common and rare virulence factors detected among the isolates were rtxC (165 isolates) and tcpP (50 isolates) respectively. All isolates from 2014 and 2015 were multidrug resistant against the selected antibiotics. MLVA differentiated the isolates into 2 large unique clones A and B, with each predominating in a particular year. Spatial analysis showed clustering of most isolates at Ablekuma sub-district. Identification of several virulence genes among the two different genotypes of V. cholerae isolates and resistance to first- and second-line antibiotics, calls for scaleup of preventive strategies to reduce transmission, and strengthening of public health laboratories for rapid antimicrobial susceptibility testing to guide accurate treatment. Our findings support the current WHO licensed cholera vaccines which include both O1 Inaba and Ogawa serotypes. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
23. Genotypic and epidemiological characterization of Mycobacterium tuberculosis complex in Ghana
- Author
-
Asante-Poku, Adwoa, Gagneux, Sébastien, and Jong, Bouke de
- Abstract
Tuberculosis (TB) remains a public health challenge. In 2013, TB was estimated to have caused 9 million incident cases of which 1.1 million were co infected with HIV and 1.5 million deaths worldwide. For the effective control of TB, the use of simplified diagnostic tools for case detection diagnosis of drug resistant TB and understanding the effects of comorbidities such as HIV on the prevalence of TB is paramount. Ghana, housing six of the seven phylogenetic lineages of Mycobacterium tuberculosis complex (MTBC) with high TB/HIV prevalence provides a unique opportunity to study and better understand the dynamics of TB. In the context of TB control, we studied the level of drug resistance using phenotypic drug susceptibility testing (DST) and correlated the DST results with patient treatment outcome (Chapter 3). We found a low rate of multidrug-resistant (MDR)-TB rate (1.9%), high isoniazid (INH) mono resistance (15%) and the dependence of treatment outcome on the susceptibility to rifampicin (RIF). For the rapid diagnosis of MDR cases, we further evaluated the accuracy of a molecular base diagnostic tool (Genotype MTBDRplus) and compared it with the gold standard phenotypic DST method (Chapter4). We found 100% correlation for detection of both MDR and RIF mono resistance and 83% for INH mono resistance. The remaining 17% INH resistance detected by standard phenotypic DST but not Genotype MTBDRplus are likely due to molecular mechanisms whose targets are not interrogated by Genotype MTBDRplus. The high overall sensitivity and the relative short turn- around time of Genotype MTBDRplus makes it a valuable addition to diagnostic algorithm in Ghana. The control of TB also depends on understanding the patterns and dynamics of TB transmission to reduce source of infection. Existing tools for studying transmission such as MIRU-15 used for routine molecular epidemiological studies have been shown to exhibit varying discriminatory power among the different human-associated MTBC lineages. We established a robust and cost-effective PCR based reduced but lineage-specific set of MIRU-VNTR loci with high discrimination power in the main MTBC circulating in Ghana (Chapter 5). This assay will help identify risk factors that enhance transmission and patient groups at increased risk of developing TB. In addition, this assay can be used to differentiate between exogenous re-infection from true relapse cases SNP- based genotyping and spoligotyping established that M. africanum (MAF) still causes 20% of all TB cases in Ghana (Chapter 6 and 7). Reasons for the restriction of MAF to West Africa have eluded researchers for many years. Using retrospective isolates, we provide for the first time plausible reason why MAF is restricted to parts of West Africa. We showed a significant association between MAF and the Ewe ethnic group. This association was confirmed using prospective isolates and supports possible host pathogen co-evolution inn TB. In addition, we observed a strong association between MAF2 and HIV co-infection supporting the notion that MAF might have a lower virulence compared to other MTBC in humans
- Published
- 2015
- Full Text
- View/download PDF
24. Molecular epidemiology and whole genome sequencing analysis of clinical Mycobacterium bovis from Ghana.
- Author
-
Otchere, Isaac Darko, van Tonder, Andries J., Asante-Poku, Adwoa, Sánchez-Busó, Leonor, Coscollá, Mireia, Osei-Wusu, Stephen, Asare, Prince, Aboagye, Samuel Yaw, Ekuban, Samuel Acquah, Yahayah, Abdallah Iddrisu, Forson, Audrey, Baddoo, Akosua, Laryea, Clement, Parkhill, Julian, Harris, Simon R., Gagneux, Sebastien, and Yeboah-Manu, Dorothy
- Subjects
MYCOBACTERIUM bovis ,TUBERCULOSIS in cattle ,TUBERCULOSIS risk factors ,MOLECULAR epidemiology ,NUCLEOTIDE sequencing - Abstract
Background: Bovine tuberculosis (bTB) caused by Mycobacterium bovis is a re-emerging problem in both livestock and humans. The association of some M. bovis strains with hyper-virulence, MDR-TB and disseminated disease makes it imperative to understand the biology of the pathogen. Methods: Mycobacterium bovis (15) among 1755 M. tuberculosis complex (MTBC) isolated between 2012 and 2014 were characterized and analyzed for associated patient demography and other risk factors. Five of the M. bovis isolates were whole-genome sequenced and comparatively analyzed against a global collection of published M. bovis genomes. Results: Mycobacterium bovis was isolated from 3/560(0.5%) females and 12/1195(1.0%) males with pulmonary TB. The average age of M. bovis infected cases was 46.8 years (7-72years). TB patients from the Northern region of Ghana (1.9%;4/212) had a higher rate of infection with M. bovis (OR = 2.7,p = 0.0968) compared to those from the Greater Accra region (0.7%;11/1543). Among TB patients with available HIV status, the odds of isolating M. bovis from HIV patients (2/119) was 3.3 higher relative to non-HIV patients (4/774). Direct contact with livestock or their unpasteurized products was significantly associated with bTB (p<0.0001, OR = 124.4,95% CI = 30.1–508.3). Two (13.3%) of the M. bovis isolates were INH resistant due to the S315T mutation in katG whereas one (6.7%) was RIF resistant with Q432P and I1491S mutations in rpoB. M. bovis from Ghana resolved as mono-phyletic branch among mostly M. bovis from Africa irrespective of the host and were closest to the root of the global M. bovis phylogeny. M. bovis-specific amino acid mutations were detected among MTBC core genes such as mce1A, mmpL1, pks6, phoT, pstB, glgP and Rv2955c. Additional mutations P6T in chaA, G187E in mgtC, T35A in Rv1979c, S387A in narK1, L400F in fas and A563T in eccA1 were restricted to the 5 clinical M. bovis from Ghana. Conclusion: Our data indicate potential zoonotic transmission of bTB in Ghana and hence calls for intensified public education on bTB, especially among risk groups. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
25. TB-diabetes co-morbidity in Ghana: The importance of Mycobacterium africanum infection.
- Author
-
Asante-Poku, Adwoa, Asare, Prince, Baddoo, Nyonuku Akosua, Forson, Audrey, Klevor, Pius, Otchere, Isaac Darko, Aboagye, Sammy Yaw, Osei-Wusu, Stephen, Danso, Emelia Konadu, Koram, Kwadwo, Gagneux, Sebastien, and Yeboah-Manu, Dorothy
- Subjects
- *
MYCOBACTERIUM , *DIAGNOSIS of diabetes , *BLOOD sugar , *GLYCOSYLATED hemoglobin - Abstract
Background: Diabetes Mellitus (DM) is a known risk factor for tuberculosis (TB) but little is known on TB-Diabetes Mellitus (TBDM) co-morbidity in Sub-Saharan Africa. Methods: Consecutive TB cases registered at a tertiary facility in Ghana were recruited from September 2012 to April 2016 and screened for DM using random blood glucose and glycated hemoglobin (HbA1c) level. TB patients were tested for other clinical parameters including HIV co-infection and TB lesion location. Mycobacterial isolates obtained from collected sputum samples were characterized by standard methods. Associations between TBDM patients’ epidemiological as well as microbiological variables were assessed. Results: The prevalence of DM at time of diagnosis among 2990 enrolled TB cases was 9.4% (282/2990). TBDM cases were significantly associated with weight loss, poor appetite, night sweat and fatigue (p<0.001) and were more likely (p<0.001) to have lower lung cavitation 85.8% (242/282) compared to TB Non-Diabetic (TBNDM) patients 3.3% (90/2708). We observed 22.3% (63/282) treatment failures among TBDM patients compared to 3.8% (102/2708) among TBNDM patients (p<0.001). We found no significant difference in the TBDM burden attributed by M. tuberculosis sensu stricto (Mtbss) and Mycobacterium africanum (Maf) and (Mtbss; 176/1836, 9.6% and Maf; 53/468, 11.3%, p = 0.2612). We found that diabetic individuals were suggestively likely to present with TB caused by M. africanum Lineage 6 as opposed to Mtbss (odds ratio (OR) = 1.52; 95% confidence interval (CI): 0.92–2.42, p = 0.072). Conclusion: Our findings confirms the importance of screening for diabetes during TB diagnosis and highlights the association between genetic diversity and diabetes. in Ghana. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
26. Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem.
- Author
-
Senyonjo, Laura G., Debrah, Oscar, Martin, Diana L., Asante-Poku, Adwoa, Migchelsen, Stephanie J., Gwyn, Sarah, deSouza, Dzeidzom K., Solomon, Anthony W., Agyemang, David, Biritwum-Kwadwo, Nana, Marfo, Benjamin, Bakajika, Didier, Mensah, Ernest O., Aboe, Agatha, Koroma, Joseph, Addy, James, and Bailey, Robin
- Subjects
TRACHOMA prevention ,CHLAMYDIA infections ,POLYMERASE chain reaction ,SEROLOGY ,PUBLIC health - Abstract
Background: Validation of elimination of trachoma as a public health problem is based on clinical indicators, using the WHO simplified grading system. Chlamydia trachomatis (Ct) infection and anti-Ct antibody responses (anti-Pgp3) have both been evaluated as alternative indicators in settings with varying levels of trachoma. There is a need to evaluate the feasibility of using tests for Ct infection and anti-Pgp3 antibodies at scale in a trachoma-endemic country and to establish the added value of the data generated for understanding transmission dynamics in the peri-elimination setting. Methodology/Principal findings: Dried blood spots for serological testing and ocular swabs for Ct infection testing (taken from children aged 1–9 years) were integrated into the pre-validation trachoma surveys conducted in the Northern and Upper West regions of Ghana in 2015 and 2016. Ct infection was detected using the GeneXpert PCR platform and the presence of anti-Pgp3 antibodies was detected using both the ELISA assay and multiplex bead array (MBA). The overall mean cluster-summarised TF prevalence (the clinical indicator) was 0.8% (95% CI: 0.6–1.0) and Ct infection prevalence was 0.04% (95%CI: 0.00–0.12). Anti-Pgp3 seroprevalence using the ELISA was 5.5% (95% CI: 4.8–6.3) compared to 4.3% (95%CI: 3.7–4.9) using the MBA. There was strong evidence from both assays that seropositivity increased with age (p<0.001), although the seroconversion rate was estimated to be very low (between 1.2 to 1.3 yearly events per 100 children). Conclusions/Significance: Infection and serological data provide useful information to aid in understanding Ct transmission dynamics. Elimination of trachoma as a public health problem does not equate to the absence of ocular Ct infection nor cessation in acquisition of anti-Ct antibodies. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
27. OMNIgene SPUTUM: A good transport and decontaminating reagent for tuberculosis testing.
- Author
-
Asandem, Diana, Asante-Poku, Adwoa, Asare, Prince, Aboagye, Sammy, Stephen, Osei-Wusu, Danso, Emelia, Klevor, Pius, Hayibor, Kenneth, and Yeboah-Manu, Dorothy
- Abstract
Background: Sputum culture is limited to centralized facilities. Thus, samples require transportation from peripheral laboratories to these facilities, compromising specimen quality since it is difficult to maintain cold chain. We evaluated OMNIgene SPUTUM Reagent (OMS) for transporting sputum samples for tuberculosis (TB) testing. The study was carried out at Noguchi Memorial Institute for Medical Research using sputa from Korle Bu Teaching Hospital and La General Hospital in Ghana. Methods: In a laboratory-based controlled experiment (CE), sputum contaminants were determined on blood agar before treatment with OMS and N-acetyl-L-cysteine-sodium hydroxide (NALC-NaOH). TB testing included smear microscopy, culture, and Xpert MTB/RIF. Afterward, two peripheral laboratories were trained to transport sputum samples with OMS without cold chain. Positivity, negativity, and contamination rates were compared between both methods using Chi-square and Fisher's exact tests. Cohen's Kappa was also used to determine agreements. Results: Among 104 sputum samples analyzed in the CE, 93 (89.4%) had bacterial growth on blood agar before decontamination, while 6 (5.8%) and 5 (4.8%) contaminated after NALC-NaOH and OMS treatment, respectively. Contamination was high with NALC-NaOH (12.8%) than OMS (4.3%) on Lowenstein–Jensen media (P < 0.001), but mycobacterial positivity was comparable: NALC-NaOH of 74.5% and OMS of 78.7%. Smear positivity after NALC-NaOH treatment was 89.4% and OMS was 75.9% (P = 0.491). All except one of the samples tested positive by Xpert MTB/RIF after both treatment. Sixteen samples were evaluated in the field experiment and 81.3% yielded positive culture, and no contamination on LJ was observed. Conclusion: Our findings indicate that OMS works well as a transport and decontaminating reagent of samples for TB testing. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
28. Laboratory confirmation of Buruli ulcer cases in Ghana, 2008-2016.
- Author
-
Yeboah-Manu, Dorothy, Aboagye, Sammy Yaw, Asare, Prince, Asante-Poku, Adwoa, Ampah, Kobina, Danso, Emelia, Owusu-Mireku, Evelyn, Nakobu, Zuleihatu, and Ampadu, Edwin
- Subjects
BURULI ulcer ,MYCOBACTERIAL diseases ,TISSUE wounds ,OSTEOMYELITIS ,EDEMA - Abstract
Background: Buruli ulcer (BU), a necrotizing skin infection caused by Mycobacterium ulcerans is the third most important mycobacterial disease globally after tuberculosis and leprosy in immune competent individuals. This study reports on the retrospective analyses of microbiologically confirmed Buruli ulcer (BU) cases in seventy-five health facilities in Ghana. Method/Principal findings: Pathological samples were collected from BU lesions and transported either through courier services or by car directly to the laboratory. Samples were processed and analysed by IS2404 PCR, culture and Ziehl-Neelsen staining for detection of acid-fast bacilli. From 2008 to 2016, we analysed by PCR, 2,287 samples of 2,203 cases from seventy-five health facilities in seven regions of Ghana (Ashanti, Brong Ahafo, Central, Eastern Greater Accra, Northern and Volta). The mean annual positivity rate was 46.2% and ranged between 14.6% and 76.2%. The yearly positivity rates from 2008 to 2016 were 52.3%, 76.2%, 56.7%, 53.8, 41.2, 41.5%, 22.9, 28.5 and 14.6% respectively. Of the 1,020 confirmed cases, the ratio of female to male was 518 and 502 respectively. Patients who were 15 years of age and below accounted for 39.8% of all cases. The median age was 20 years (IQR = 10–43). Ulcerative lesions were 69.2%, nodule (9.6%), plaque (2.9%), oedema (2.5%), osteomyelitis (1.1%), ulcer/oedema (9.5%) and ulcer/plaque (5.2%). Lesions frequently occurred on the lower limbs (57%) followed by the upper limbs (38%), the neck and head (3%) and the least found on the abdomen (2%). Conclusions/Significance: Our findings show a decline in microbiological confirmed rates over the years and therefore call for intensive education on case recognition to prevent over-diagnosis as BU cases decline. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
29. Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case.
- Author
-
Osei-Wusu, Stephen, Omari, Michael Amo, Asante-Poku, Adwoa, Otchere, Isaac Darko, Asare, Prince, Forson, Audrey, Otu, Jacob, Antonio, Martin, and Yeboah-Manu, Dorothy
- Subjects
TUBERCULOSIS diagnosis ,TUBERCULOSIS prevention ,ANTITUBERCULAR agents ,DRUG resistance in bacteria ,MOXIFLOXACIN ,THERAPEUTICS - Abstract
Background: Drug resistance surveillance is crucial for tuberculosis (TB) control. Therefore, our goal was to determine the prevalence of second-line anti-TB drug resistance among diverse primary drug-resistant Mycobacterium tuberculosis complex (MTBC) isolates in Ghana. Materials and methods: One hundred and seventeen MTBC isolates with varying first-line drug resistance were analyzed. Additional resistance to second-line anti-TB drugs (streptomycin [STR], amikacin [AMK] and moxifloxacin [MOX]) was profiled using the Etest and GenoType MTBDRsl version 2.0. Genes associated with resistance to AMK and MOX (gyrA, gyrB, eis, rrs, tap, whiB7 and tlyA) were then analyzed for mutation. Results: Thirty-seven (31.9%) isolates had minimum inhibitory concentration (MIC) values =2 µg/mL against STR while 12 (10.3%) isolates had MIC values =1 µg/mL for AMK. Only one multidrug-resistant (MDR) isolate (Isolate ID: TB/Nm 919) had an MIC value of =0.125 µg/mL for MOX (MIC = 3 μg/mL). This isolate also had the highest MIC value for AMK (MIC = 16 μg/mL) and was confirmed as resistant to AMK and MOX by the line probe assay GenoType MTBDRsl version 2.0. Mutations associated with the resistance were: gyrA (G88C) and rrs (A514C and A1401G). Conclusion: Our findings suggest the need to include routine second-line anti-TB drug susceptibility testing of MDR/rifampicin-resistant isolates in our diagnostic algorithm. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
30. Isolation and Characterization of Nontuberculous Mycobacteria from Patients with Pulmonary Tuberculosis in Ghana.
- Author
-
Otchere, Isaac Darko, Asante-Poku, Adwoa, Osei-Wusu, Stephen, Aboagye, Samuel Yaw, and Yeboah-Manu, Dorothy
- Abstract
Objective/Background: Nontuberculous mycobacterial (NTM) species are assuming public health importance in pulmonary diseases; they are increasingly being isolated, and importantly, most NTMs do not respond to routine tuberculosis (TB) drugs. This study aimed to identify NTMs isolated from pulmonary TB cases and also determine their susceptibility to streptomycin (STR), isoniazid (INH), and rifampicin (RIF). Methods: A total of 1755 mycobacterial isolates, obtained between August 2012 and July 2014, from 2036 smear-positive pulmonary cases were identified using polymerase chain reaction amplification of IS6110, and hsp65 gene sequencing analysis. Drug susceptibility testing (DST) was then performed for the identified NTMs against STR, INH, and RIF using microplate Alamar blue assay. The results were analyzed against patients' biodata for statistical associations. Results: Of the 1755 analyzed isolates, we identified 43 (2.5%) NTMs, which included 18 (41.9%) Mycobacterium intracellulare, 13 (30.2%) Mycobacterium avium subs. paratuberculosis, 5 (11.3%) Mycobacterium abscessus, 3 (7.0%) each of Mycobacterium mucogenicum and Mycobacterium colombiense, and 1 (2.3%) Mycobacterium simiae. Patients infected with NTMs (52.0%) were more likely to be human immunodeficiency virus-positive (P = 0.001, odds ratio = 6.6, 95% confidence interval = 2.7-16.2) than those infected with M. tuberculosis complex (5.8%). All the 43 (100%) NTMs were resistant to INH, whereas 32 (74%) and 19 (44%) were resistant to RIF and STR, respectively. Furthermore, 16 (37.2%) NTMs were resistant to all three drugs, 20 were resistant to INH and RIF, and 3 were resistant to STR and INH. All the M. abscessus isolates were resistant to all the three drugs, whereas all the M. avium isolates were resistant to INH and RIF, but only three were resistant to STR. Among the M. intracellulare isolates, 8, 18, and 15 isolates were resistant to STR, INH, and RIF, respectively. Conclusion: The observed high-resistance level to INH and RIF supports the need for rapid species identification and DST of nonresponding TB cases before retreatment. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
31. Molecular epidemiology of Mycobacterium africanum in Ghana.
- Author
-
Asante-Poku, Adwoa, Darko Otchere, Isaac, Osei-Wusu, Stephen, Sarpong, Esther, Baddoo, Akosua, Forson, Audrey, Laryea, Clement, Borrell, Sonia, Bonsu, Frank, Hattendorf, Jan, Ahorlu, Collins, Koram, Kwadwo A., Gagneux, Sebastien, Yeboah-Manu, Dorothy, and Otchere, Isaac Darko
- Subjects
- *
MYCOBACTERIUM , *PHYLOGENY , *TUBERCULOSIS , *PATHOGENIC microorganisms , *PUBLIC health - Abstract
Background: Mycobacterium africanum comprises two phylogenetic lineages within the M. tuberculosis complex (MTBC) and is an important cause of human tuberculosis (TB) in West Africa. The reasons for this geographic restriction of M. africanum remain unclear. Here, we performed a prospective study to explore associations between the characteristics of TB patients and the MTBC lineages circulating in Ghana.Method: We genotyped 1,211 MTBC isolates recovered from pulmonary TB patients recruited between 2012 and 2014 using single nucleotide polymorphism typing and spoligotyping. Associations between patient and pathogen variables were assessed using univariate and multivariate logistic regression.Results: Of the 1,211 MTBC isolates analysed, 71.9 % (871) belonged to Lineage 4; 12.6 % (152) to Lineage 5 (also known as M. africanum West-Africa 1), 9.2 % (112) to Lineage 6 (also known as M. africanum West-Africa 2) and 0.6 % (7) to Mycobacterium bovis. Univariate analysis revealed that Lineage 6 strains were less likely to be isoniazid resistant compared to other strains (odds ratio = 0.25, 95 % confidence interval (CI): 0.05-0.77, P < 0.01). Multivariate analysis showed that Lineage 5 was significantly more common in patients from the Ewe ethnic group (adjusted odds ratio (adjOR): 2.79; 95 % CI: 1.47-5.29, P < 0.001) and Lineage 6 more likely to be found among HIV-co-infected TB patients (adjOR = 2.2; 95 % confidence interval (CI: 1.32-3.7, P < 0.001).Conclusion: Our findings confirm the importance of M. africanum in Ghana and highlight the need to differentiate between Lineage 5 and Lineage 6, as these lineages differ in associated patient variables. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
32. Spatiotemporal Co-existence of Two Mycobacterium ulcerans Clonal Complexes in the Offin River Valley of Ghana.
- Author
-
Lamelas, Araceli, Ampah, Kobina Assan, Aboagye, Samuel, Kerber, Sarah, Danso, Emelia, Asante-Poku, Adwoa, Asare, Prince, Parkhill, Julian, Harris, Simon R., Pluschke, Gerd, Yeboah-Manu, Dorothy, and Röltgen, Katharina
- Subjects
BURULI ulcer ,MYCOBACTERIUM ,SKIN diseases ,INVERTEBRATES as carriers of disease ,PATHOGENIC bacteria - Abstract
In recent years, comparative genome sequence analysis of African Mycobacterium ulcerans strains isolated from Buruli ulcer (BU) lesion specimen has revealed a very limited genetic diversity of closely related isolates and a striking association between genotype and geographical origin of the patients. Here, we compared whole genome sequences of five M. ulcerans strains isolated in 2004 or 2013 from BU lesions of four residents of the Offin river valley with 48 strains isolated between 2002 and 2005 from BU lesions of individuals residing in the Densu river valley of Ghana. While all M. ulcerans isolates from the Densu river valley belonged to the same clonal complex, members of two distinct clonal complexes were found in the Offin river valley over space and time. The Offin strains were closely related to genotypes from either the Densu region or from the Asante Akim North district of Ghana. These results point towards an occasional involvement of a mobile reservoir in the transmission of M. ulcerans, enabling the spread of bacteria across different regions. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
33. Mycobacterium africanum Is Associated with Patient Ethnicity in Ghana.
- Author
-
Asante-Poku, Adwoa, Yeboah-Manu, Dorothy, Otchere, Isaac Darko, Aboagye, Samuel Y., Stucki, David, Hattendorf, Jan, Borrell, Sonia, Feldmann, Julia, Danso, Emelia, and Gagneux, Sebastien
- Subjects
- *
MYCOBACTERIA , *MYCOBACTERIUM , *MYCOBACTERIUM tuberculosis , *BURULI ulcer , *MYCOBACTERIUM avium paratuberculosis , *HUMAN genetic variation , *TUBERCULOSIS patients , *ETHNICITY - Abstract
Mycobacterium africanum is a member of the Mycobacterium tuberculosis complex (MTBC) and an important cause of human tuberculosis in West Africa that is rarely observed elsewhere. Here we genotyped 613 MTBC clinical isolates from Ghana, and searched for associations between the different phylogenetic lineages of MTBC and patient variables. We found that 17.1% (105/613) of the MTBC isolates belonged to M. africanum, with the remaining belonging to M. tuberculosis sensu stricto. No M. bovis was identified in this sample. M. africanum was significantly more common in tuberculosis patients belonging to the Ewe ethnic group (adjusted odds ratio: 3.02; 95% confidence interval: 1.67–5.47, p<0.001). Stratifying our analysis by the two phylogenetic lineages of M. africanum (i.e. MTBC Lineages 5 and 6) revealed that this association was mainly driven by Lineage 5 (also known as M. africanum West Africa 1). Our findings suggest interactions between the genetic diversity of MTBC and human diversity, and offer a possible explanation for the geographical restriction of M. africanum to parts of West Africa. Author Summary: Tuberculosis remains one of the main global public health problems. Human tuberculosis is caused by bacteria known as the Mycobacterium tuberculosis complex (MTBC). The MTBC includes a variant called Mycobacterium africanum, which causes up to half of all tuberculosis cases in West Africa. For reasons unknown, M. africanum does not occur in other parts of the world. To explore the possible reasons for this geographic restriction of M. africanum, we analysed a large collection of bacterial strains isolated from tuberculosis patients in Ghana. We genetically characterized these bacterial isolates and collected relevant socio-demographic and epidemiological data. We found tuberculosis patients infected with M. africanum were more likely to belong to the Ewe ethnic group, compared to patients carrying other MTBC bacteria. The Ewes are indigenous inhabitants of coastal regions in West Africa that have previously been shown to harbour a high prevalence of M. africanum. Our findings support the hypothesis that different variants of MTBC have adapted to different human populations, and offer a possible explanation for the geographical restriction of M. africanum to West Africa. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
34. Prevalence of bovine tuberculosis in a dairy cattle farm and a research farm in Ghana.
- Author
-
Asante-Poku, Adwoa, Aning, Kwame G., Bashiru Boi-Kikimoto, and Yeboah-Manu, Dorothy
- Abstract
The article focuses on a study that was conducted to examine the prevalence of bovine tuberculosis (BTB) in a dairy farm and research farm in Ghana. Topics discussed under study include screening of cattle for BTB by using the comparative intradermal tuberculin test (CTT), carcasses being examined for the presence of mycobacterial species and speciation of isolates through molecular assays. It states that 2.48 percent among cattle from the two farms revealed BTB prevalence.
- Published
- 2014
- Full Text
- View/download PDF
35. Evaluation of Customised Lineage-Specific Sets of MIRU-VNTR Loci for Genotyping Mycobacterium tuberculosis Complex Isolates in Ghana.
- Author
-
Asante-Poku, Adwoa, Nyaho, Michael Selasi, Borrell, Sonia, Comas, Iñaki, Gagneux, Sebastien, and Yeboah-Manu, Dorothy
- Subjects
- *
MYCOBACTERIUM tuberculosis , *COMPARATIVE studies , *EPIDEMIOLOGY , *GENE expression , *COMPUTATIONAL biology , *MOLECULAR biology - Abstract
Background: Different combinations of variable number of tandem repeat (VNTR) loci have been proposed for genotyping Mycobacterium tuberculosis complex (MTBC). Existing VNTR schemes show different discriminatory capacity among the six human MTBC lineages. Here, we evaluated the discriminatory power of a “customized MIRU12” loci format proposed previously by Comas et al. based on the standard 24 loci defined by Supply et al. for VNTR-typing of MTBC in Ghana. Method: One hundred and fifty-eight MTBC isolates classified into Lineage 4 and Lineage 5 were used to compare a customized lineage-specific panel of 12 MIRU-VNTR loci (“customized MIRU-12″) to the standard MIRU-15 genotyping scheme. The resolution power of each typing method was determined based on the Hunter-Gaston- Discriminatory Index (HGDI). A minimal set of customized MIRU-VNTR loci for typing Lineages 4 (Euro-American) and 5 (M. africanum West African 1) strains from Ghana was defined based on the cumulative HGDI. Results and Conclusion: Among the 106 Lineage 4 strains, the customized MIRU-12 identified a total of 104 distinct genotypes consisting of 2 clusters of 2 isolates each (clustering rate 1.8%), and 102 unique strains while standard MIRU-15 yielded a total of 105 different genotypes, including 1 cluster of 2 isolates (clustering rate: 0.9%) and 104 singletons. Among, 52 Lineage 5 isolates, customized MIRU-12 genotyping defined 51 patterns with 1 cluster of 2 isolates (clustering rate: 0.9%) and 50 unique strains whereas MIRU-15 classified all 52 strains as unique. Cumulative HGDI values for customized MIRU-12 for Lineages 4 and 5 were 0.98 respectively whilst that of standard MIRU-15 was 0.99. A union of loci from the customised MIRU-12 and standard MIRU-15 revealed a set of customized eight highly discriminatory loci: 4052, 2163B, 40, 4165, 2165, 10,16 and 26 with a cumulative HGDI of 0.99 for genotyping Lineage 4 and 5 strains from Ghana. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
36. Sero-Epidemiology as a Tool to Screen Populations for Exposure to Mycobacterium ulcerans.
- Author
-
Yeboah-Manu, Dorothy, Röltgen, Katharina, Opare, William, Asan-Ampah, Kobina, Quenin-Fosu, Kwabena, Asante-Poku, Adwoa, Ampadu, Edwin, Fyfe, Janet, Koram, Kwadwo, Ahorlu, Collins, and Pluschke, Gerd
- Subjects
BURULI ulcer ,HEAT shock proteins ,MYCOBACTERIUM ,ANTIBODY formation ,ANTIBODY titer ,ENVIRONMENTAL sampling - Abstract
Background: Previous analyses of sera from a limited number of Ghanaian Buruli ulcer (BU) patients, their household contacts, individuals living in BU non-endemic regions as well as European controls have indicated that antibody responses to the M. ulcerans 18 kDa small heat shock protein (shsp) reflect exposure to this pathogen. Here, we have investigated to what extent inhabitants of regions in Ghana regarded as non-endemic for BU develop anti-18 kDa shsp antibody titers. Methodology/Principal Findings: For this purpose we determined anti-18 kDa shsp IgG titers in sera collected from healthy inhabitants of the BU endemic Densu River Valley and the Volta Region, which was so far regarded as BU non-endemic. Significantly more sera from the Densu River Valley contained anti-18 kDa shsp IgG (32% versus 12%, respectively). However, some sera from the Volta Region also showed high titers. When interviewing these sero-responders, it was revealed that the person with the highest titer had a chronic wound, which was clinically diagnosed and laboratory reconfirmed as active BU. After identification of this BU index case, further BU cases were clinically diagnosed by the Volta Region local health authorities and laboratory reconfirmed. Interestingly, there was neither a difference in sero-prevalence nor in IS2404 PCR positivity of environmental samples between BU endemic and non-endemic communities located in the Densu River Valley. Conclusions: These data indicate that the intensity of exposure to M. ulcerans in endemic and non-endemic communities along the Densu River is comparable and that currently unknown host and/or pathogen factors may determine how frequently exposure is leading to clinical disease. While even high serum titers of anti-18 kDa shsp IgG do not indicate active disease, sero-epidemiological studies can be used to identify new BU endemic areas. Author Summary: Sero-epidemiological analyses revealed that a higher proportion of sera from individuals living in the Buruli ulcer (BU) endemic Densu River Valley of Ghana contain Mycobacterium ulcerans 18 kDa small heat shock protein (shsp)-specific IgG than sera from inhabitants of the Volta Region, which was regarded so far as BU non-endemic. However, follow-up studies in the Volta Region showed that the individual with the highest anti-18 kDa shsp-specific serum IgG titer of all participants from the Volta Region had a BU lesion. Identification of more BU patients in the Volta Region by subsequent active case search demonstrated that sero-epidemiology can help identify low endemicity areas. Endemic and non-endemic communities along the Densu River Valley differed neither in sero-prevalence nor in positivity of environmental samples in PCR targeting M. ulcerans genomic and plasmid DNA sequences. A lower risk of developing M. ulcerans disease in the non-endemic communities may either be related to host factors or a lower virulence of local M. ulcerans strains. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
37. Combining PCR with Microscopy to Reduce Costs of Laboratory Diagnosis of Buruli Ulcer.
- Author
-
Yeboah-Manu, Dorothy, Asante-Poku, Adwoa, Asan-Ampah, Kobina, Ampadu, Emelia Danso Edwin, and Pluschke, Gerd
- Published
- 2011
- Full Text
- View/download PDF
38. Genotypic Diversity and Drug Susceptibility Patterns among M. tuberculosis Complex Isolates from South- Western Ghana.
- Author
-
Yeboah-Manu, Dorothy, Asante-Poku, Adwoa, Bodmer, Thomas, Stucki, David, Koram, Kwadwo, Bonsu, Frank, Pluschke, Gerd, and Gagneux, Sebastien
- Subjects
- *
MYCOBACTERIUM tuberculosis , *MICROBIAL sensitivity tests , *HUMAN genetic variation , *GENETIC polymorphisms , *TUBERCULOSIS vaccines , *COMPARATIVE studies - Abstract
Objective: The aim of this study was to use spoligotyping and large sequence polymorphism (LSP) to study the population structure of M. tuberculosis complex (MTBC) isolates. Methods: MTBC isolates were identified using standard biochemical procedures, IS6110 PCR, and large sequence polymorphisms. Isolates were further typed using spoligotyping, and the phenotypic drug susceptibility patterns were determined by the proportion method. Result: One hundred and sixty-two isolates were characterised by LSP typing. Of these, 130 (80.25%) were identified as Mycobacterium tuberculosis sensu stricto (MTBss), with the Cameroon sub-lineage being dominant (N = 59/130, 45.38%). Thirty-two (19.75%) isolates were classified as Mycobacterium africanum type 1, and of these 26 (81.25%) were identified as West-Africa I, and 6 (18.75%) as West-Africa II. Spoligotyping sub-lineages identified among the MTBss included Haarlem (N = 15, 11.53%), Ghana (N = 22, 16.92%), Beijing (4, 3.08%), EAI (4, 3.08%), Uganda I (4, 3.08%), LAM (2, 1.54%), X (N = 1, 0.77%) and S (2, 1.54%). Nine isolates had SIT numbers with no identified sub-lineages while 17 had no SIT numbers. MTBss isolates were more likely to be resistant to streptomycin (p<0.008) and to any drug resistance (p<0.03) when compared to M. africanum. Conclusion: This study demonstrated that overall 36.4% of TB in South-Western Ghana is caused by the Cameroon sublineage of MTBC and 20% by M. africanum type 1, including both the West-Africa 1 and West-Africa 2 lineages. The diversity of MTBC in Ghana should be considered when evaluating new TB vaccines. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
39. The First population structure and comparative genomics analysis of Mycobacterium africanum strains from Ghana reveals higher diversity of Lineage 5
- Author
-
Otchere, Isaac D., Harris, Simon R., Busso, Sanches L., Asante-Poku, Adwoa, Osei-Wusu, Stephen, Koram, Kwadwo, Parkhill, Julian, Gagneux, Sebastien, and Yeboah-Manu, Dorothy
- Published
- 2016
- Full Text
- View/download PDF
40. Enhancing Genetic Medicine: Rapid and Cost-Effective Molecular Diagnosis for a GJB2 Founder Mutation for Hearing Impairment in Ghana.
- Author
-
M. Adadey, Samuel, Tingang Wonkam, Edmond, Twumasi Aboagye, Elvis, Quansah, Darius, Asante-Poku, Adwoa, Quaye, Osbourne, K. Amedofu, Geoffrey, A. Awandare, Gordon, and Wonkam, Ambroise
- Subjects
RECESSIVE genes ,HEARING disorders ,RESTRICTION fragment length polymorphisms ,MOLECULAR diagnosis ,NEWBORN screening ,AUDIOMETRY - Abstract
In Ghana, gap-junction protein β 2 (GJB2) variants account for about 25.9% of familial hearing impairment (HI) cases. The GJB2-p.Arg143Trp (NM_004004.6:c.427C>T/OMIM: 121011.0009/rs80338948) variant remains the most frequent variant associated with congenital HI in Ghana, but has not yet been investigated in clinical practice. We therefore sought to design a rapid and cost-effective test to detect this variant. We sampled 20 hearing-impaired and 10 normal hearing family members from 8 families segregating autosomal recessive non syndromic HI. In addition, a total of 111 unrelated isolated individuals with HI were selected, as well as 50 normal hearing control participants. A restriction fragment length polymorphism (RFLP) test was designed, using the restriction enzyme NciI optimized and validated with Sanger sequencing, for rapid genotyping of the common GJB2-p.Arg143Trp variant. All hearing-impaired participants from 7/8 families were homozygous positive for the GJB2-p.Arg143Trp mutation using the NciI-RFLP test, which was confirmed with Sanger sequencing. The investigation of 111 individuals with isolated non-syndromic HI that were previously Sanger sequenced found that the sensitivity of the GJB2-p.Arg143Trp NciI-RFLP testing was 100%. All the 50 control subjects with normal hearing were found to be negative for the variant. Although the test is extremely valuable, it is not 100% specific because it cannot differentiate between other mutations at the recognition site of the restriction enzyme. The GJB2-p.Arg143Trp NciI-RFLP-based diagnostic test had a high sensitivity for genotyping the most common GJB2 pathogenic and founder variant (p.Arg143Trp) within the Ghanaian populations. We recommend the adoption and implementation of this test for hearing impairment genetic clinical investigations to complement the newborn hearing screening program in Ghana. The present study is a practical case scenario of enhancing genetic medicine in Africa. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
41. Comparative genomics of Mycobacterium africanum Lineage 5 and Lineage 6 from Ghana suggests distinct ecological niches
- Author
-
Otchere, Isaac D., Coscolla, Mireia, Sánchez-Busó, Leonor, Asante-Poku, Adwoa, Brites, Daniela, Loiseau, Chloe, Meehan, Conor, Osei-Wusu, Stephen, Forson, Audrey, Laryea, Clement, Yahayah, Abdallah I., Baddoo, Akosua, Ansa, Gloria A., Aboagye, Samuel Y., Asare, Prince, Borrell, Sonia, Gehre, Florian, Beckert, Patrick, Kohl, Thomas A., N'dira, Sanoussi, Beisel, Christian, Antonio, Martin, Niemann, Stefan, De Jong, Bouke C., Parkhill, Julian, Harris, Simon R., Gagneux, Sebastien, and Yeboah-Manu, Dorothy
- Subjects
3. Good health - Abstract
Mycobacterium africanum (Maf) causes a substantial proportion of human tuberculosis in some countries of West Africa, but little is known on this pathogen. We compared the genomes of 253 Maf clinical isolates from Ghana, including N = 175 Lineage 5 (L5) and N = 78 Lineage 6 (L6). We found that the genomic diversity of L6 was higher than in L5 despite the smaller sample size. Regulatory proteins appeared to evolve neutrally in L5 but under purifying selection in L6. Even though over 90% of the human T cell epitopes were conserved in both lineages, L6 showed a higher ratio of non-synonymous to synonymous single nucleotide variation in these epitopes overall compared to L5. Of the 10% human T cell epitopes that were variable, most carried mutations that were lineage-specific. Our findings indicate that Maf L5 and L6 differ in some of their population genomic characteristics, possibly reflecting different selection pressures linked to distinct ecological niches., Scientific Reports, 8 (1), ISSN:2045-2322
42. Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages
- Author
-
Fenner, Lukas, Vilanova, Griselda Tudo, Bower, James, Wilkinson, Robert, Gehre, Florian, Borrell, Sonia, Alani, Issam, Malla, Bijaya, Wampande, Eddie, Gao, Qian, Akter, Suriya, Stewart-Isherwood, Lynsey, Koch, Anastasia, Trauner, Andrej, Cirillo, Daniela Maria, Sanchez-Padilla, Elisabeth, Ntoumi, Francine, De Jong, Bouke C, Supply, Philip, Suffys, Philip, Hoelscher, Michael, Luo, Tao, Niemann, Stefan, Gil-Brusola, Ana, Eisenach, Kathleen, Joloba, Moses, Asante-Poku, Adwoa, Brites, Daniela, Stucki, David, Crudu, Valeriu, Kato-Maeda, Midori, Ballif, Marie, Comas, Iñaki, Barletta, Francesca, Otero, Larissa, Bakonyte, Daiva, Fyfe, Janet, Stakenas, Petras, Globan, Maria, Ndung'u, Perpetual Wangui, Moldovan, Olga, Penlap Beng, Veronique N, Beck, Hans-Peter, Liu, Qingyun, Diel, Roland, Thomas, Jackson, Moreno, Milagros, Al-Hajoj, Sahal, Basu, Indira, Toit, Kadri, Rutaihwa, Liliana, Saraiva, Margarida, Boom, W Henry, Revathi, Gunturu, Skenders, Girts, Ntinginya, Nyanda E, Ley, Serej D, Hoffner, Sven, Macedo, Rita, Bonnet, Maryline, Gail-Bekker, Linda, Carter, E Jane, Guthrie, Jennifer L, Coscolla, Mireia, Ssengooba, Willy, Jamieson, Frances, Gagneux, Sebastien, Rachow, Andrea, Mardassi, Helmi, Diero, Lameck, Jeljeli, Leïla, Yeboah-Manu, Dorothy, Frank, Matthias, Vasconcellos, Sidra E G, and Egger, Matthias
- Subjects
610 Medicine & health ,360 Social problems & social services ,3. Good health
43. Improving experiences of neglected tropical diseases of the skin: Mixed methods formative research for development of a complex intervention in Atwima Mponua District, Ghana.
- Author
-
Okyere D, Ocloo EK, Owusu L, Amoako YA, Tuwor RD, Koka E, Novignon J, Asante-Poku A, Siam IM, Afreh EK, Agbanyo A, Akuffo RA, Gyabaah S, Oppong MN, Halliday KE, Simpson H, Timothy J, Marks M, Zuurmond M, Walker SL, Pullan RL, Ahorlu CS, Phillips RO, Yeboah-Manu D, Pitt C, and Palmer J
- Abstract
Integrated approaches to managing co-endemic neglected tropical diseases (NTDs) of the skin within primary healthcare services are complex and require tailoring to local contexts. We describe formative research in Atwima Mponua District in Ghana's Ashanti Region designed to inform the development of a sustainable intervention to improve access to skin NTD care. We employed a convergent, parallel, mixed-methods design, collecting data from February 2021 to February 2022. We quantitatively assessed service readiness using a standardised checklist and reviewed outpatient department registers and condition-specific case records in all government health facilities in the district. Alongside a review of policy documents, we conducted 49 interviews and 7 focus group discussions with purposively selected affected persons, caregivers, community members, health workers, and policy-makers to understand skin NTD care-seeking practices and the policy landscape. Outside the district hospital, skin NTD reporting rates in the surveyed facilities were low; supply chains for skin NTD diagnostics, consumables, and medicines had gaps; and health worker knowledge of skin NTDs was limited. Affected people described fragmented care, provided mostly by hospitals (often outside the district) or traditional healers, resulting in challenges obtaining timely diagnosis and treatment and high care-seeking costs. Affected people experienced stigma, although the extent to which stigma influenced care-seeking behaviour was unclear. National actors were more optimistic than district-level actors about local resource availability for skin NTD care and were sceptical of including traditional healers in interventions. Our findings indicate that improvement of the care cascade for affected individuals to reduce the clinical, economic, and psychosocial impact of skin NTDs is likely to require a complementary set of interventions. These findings have informed the design of a strategy to support high-quality, integrated, decentralised care for skin NTDs in Atwima Mponua, which will be assessed through a multidisciplinary evaluation., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Okyere et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
44. Development of an integrated and decentralised skin health strategy to improve experiences of skin neglected tropical diseases and other skin conditions in Atwima Mponua District, Ghana.
- Author
-
Phillips RO, Owusu L, Koka E, Ocloo EK, Simpson H, Agbanyo A, Okyere D, Tuwor RD, Fokuoh-Boadu A, Akuffo RA, Novignon J, Oppong MN, Mosweu I, Asante-Poku A, Cobbinah J, Mtuy TB, Palmer J, Ahorlu C, Amoako YA, Walker SL, Yeboah-Manu D, Marks M, Pitt C, and Pullan R
- Abstract
Integrated strategies are recommended to tackle neglected tropical diseases of the skin (skin NTDs), which pose a substantial health and economic burden in many countries, including Ghana. We describe the development of an integrated and decentralised skin health strategy designed to improve experiences of skin NTDs in Atwima Mponua district in Ashanti Region. A multidisciplinary research team led an iterative process to develop an overall strategy and specific interventions, based on a theory of change informed by formative research conducted in Atwima Mponua district. The process involved preparatory work, four co-development workshops (August 2021 to November 2022), collaborative working groups to operationalise intervention components, and obtaining ethical approval. Stakeholders including affected individuals, caregivers, other community members and actors from different levels of the health system participated in co-development activities. We consulted these stakeholders at each stage of the research process, including discussion of study findings, development of our theory of change, identifying implementable solutions to identified challenges, and protocol development. Participants determined that the intervention should broadly address wounds and other skin conditions, rather than only skin NTDs, and should avoid reliance on non-governmental organisations and research teams to ensure sustainable implementation by district health teams and transferability elsewhere. The overall strategy was designed to focus on a decentralised model of care for skin conditions, while including other interventions to support a self-care delivery pathway, community engagement, and referral. Our theory of change describes the pathways through which these interventions are expected to achieve the strategy's aim, the assumptions, and problems addressed. This complex intervention strategy has been designed to respond to the local context, while maximising transferability to ensure wider relevance. Implementation is expected to begin in 2023., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Phillips et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
45. Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in Mycobacterium ulcerans disease, a protocol for a randomised controlled trial in Ghana.
- Author
-
Amoako YA, Agbanyo A, Novignon J, Owusu L, Tuffour J, Asante-Poku A, Hailemichael Y, Mosweu I, Canter R, Opondo C, Allen E, Pitt C, Yeboah-Manu D, Walker SL, Marks M, and Phillips RO
- Abstract
Background: Buruli ulcer (BU) can lead to disfiguring ulcers and permanent disability. The 2030 World Health Organization (WHO) road map for Neglected Tropical Diseases (NTDs) calls for major scaling up in diagnosis and management to eliminate disability due to the disease. Current treatment for BU is with daily oral rifampicin (10mg/kg dose) and clarithromycin (15mg/kg dose) for eight weeks, combined with standard gauze wound dressings. Dialkylcarbamoyl chloride (DACC)-coated dressings have been shown to irreversibly bind bacteria on wound surfaces resulting in their removal when dressings are changed. This trial aims to determine whether combining a high-dose oral rifampicin regimen with DACC dressings can improve the rate of wound healing relative to standard-dose oral rifampicin combined with DACC dressings., Methods: This is an individual, multi-centre Phase 3 randomised controlled trial, which will be conducted in three clinical sites in Ghana. The primary outcome measure will be the mean time to clearance of viable mycobacteria. Cost and health-related quality of life data will be collected, and a cost-effectiveness analysis will be performed., Discussion: The findings from this trial could lead to a change in how BU is treated. A shorter but more efficacious regimen would lead to improved treatment outcomes and potentially substantial financial and economic savings., Trial Registration: Pan African Clinical Trials Repository (registration number; PACTR202011867644311). Registered on 30
th November 2020., Competing Interests: No competing interests were disclosed., (Copyright: © 2023 Amoako YA et al.)- Published
- 2023
- Full Text
- View/download PDF
46. Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases.
- Author
-
Otchere ID, Morgan PA, Asare P, Osei-Wusu S, Aboagye SY, Yirenkyi SO, Musah AB, Danso EK, Tetteh-Ocloo G, Afum T, Asante-Poku A, Laryea C, Poku YA, Bonsu F, Gagneux S, and Yeboah-Manu D
- Abstract
Background: Resistance to tuberculosis (TB) drugs has become a major threat to global control efforts. Early case detection and drug susceptibility profiling of the infecting bacteria are essential for appropriate case management. The objective of this study was to determine the drug susceptibility profiles of difficult-to-treat (DTT) TB patients in Ghana., Methods: Sputum samples obtained from DTT-TB cases from health facilities across Ghana were processed for rapid diagnosis and detection of drug resistance using the Genotype MTBDR plus and Genotype MTBDR sl . v2 from Hain Life science., Results: A total of 298 (90%) out of 331 sputum samples processed gave interpretable bands out of which 175 (58.7%) were resistant to at least one drug (ANY
r ); 16.8% (50/298) were isoniazid-mono-resistant (INHr ), 16.8% (50/298) were rifampicin-mono-resistant (RIFr ), and 25.2% (75/298) were MDR. 24 (13.7%) of the ANYr were additionally resistant to at least one second line drug: 7.4% (2 RIFr , 1 INHr , and 10 MDR samples) resistant to only FQs and 2.3% (2 RIFr , 1 INHr , and 1 MDR samples) resistant to AMG drugs kanamycin (KAN), amikacin (AMK), capreomycin (CAP), and viomycin (VIO). Additionally, there were 4.0% (5 RIFr and 2 MDR samples) resistant to both FQs and AMGs. 81 (65.6%) out of 125 INH-resistant samples including INHr and MDR had katG -mutations (MT) whereas 15 (12%) had inhApro -MT. The remaining 28 (22.4%) had both katG and inhA MT. All the 19 FQ-resistant samples were gyrA mutants whereas the 10 AMGs were rrs (3), eis (3) as well as rrs , and eis co-mutants (4). Except for the seven pre-XDR samples, no sample had eis MT., Conclusion: The detection of several pre-XDR TB cases in Ghana calls for intensified drug resistance surveillance and monitoring of TB patients to, respectively, ensure early diagnosis and treatment compliance., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Otchere, Morgan, Asare, Osei-Wusu, Aboagye, Yirenkyi, Musah, Danso, Tetteh-Ocloo, Afum, Asante-Poku, Laryea, Poku, Bonsu, Gagneux and Yeboah-Manu.)- Published
- 2023
- Full Text
- View/download PDF
47. Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in Mycobacterium ulcerans disease, a protocol for a randomised controlled trial in Ghana [version 1; peer review: 2 approved].
- Author
-
Amoako YA, Agbanyo A, Novignon J, Owusu L, Tuffour J, Asante-Poku A, Hailemichael Y, Mosweu I, Canter R, Opondo C, Allen E, Pitt C, Yeboah-Manu D, Walker SL, Marks M, and Phillips RO
- Abstract
Background: Buruli ulcer (BU) can lead to disfiguring ulcers and permanent disability. The 2030 World Health Organization (WHO) road map for Neglected Tropical Diseases (NTDs) calls for major scaling up in diagnosis and management to eliminate disability due to the disease. Current treatment for BU is with daily oral rifampicin (10mg/kg dose) and clarithromycin (15mg/kg dose) for eight weeks, combined with standard gauze wound dressings. Dialkylcarbamoyl chloride (DACC)-coated dressings have been shown to irreversibly bind bacteria on wound surfaces resulting in their removal when dressings are changed. This trial aims to determine whether combining a high-dose oral rifampicin regimen with DACC dressings can improve the rate of wound healing relative to standard-dose oral rifampicin combined with DACC dressings., Methods: This is an individual, multi-centre Phase 3 randomised controlled trial, which will be conducted in three clinical sites in Ghana. The primary outcome measure will be the mean time to clearance of viable mycobacteria. Cost and health-related quality of life data will be collected, and a cost-effectiveness analysis will be performed., Discussion: The findings from this trial could lead to a change in how BU is treated. A shorter but more efficacious regimen would lead to improved treatment outcomes and potentially substantial financial and economic savings., Competing Interests: Competing interests: No competing interests were disclosed.
- Published
- 2022
- Full Text
- View/download PDF
48. Primary Isolation of Mycobacterium ulcerans.
- Author
-
Yeboah-Manu D, Asante-Poku A, and Yaw Aboagye S
- Subjects
- Anti-Infective Agents, Culture Media, Glycerol, Mycobacterium ulcerans
- Abstract
Primary isolation of Mycobacterium ulcerans is the separation and growth of the bacterium from a mixed population either in clinical specimen or environmental specimen in pure cultures. It is a crucial activity as it can be used to monitor antimicrobial treatment, surveillance for antimicrobial resistance, and molecular epidemiology studies toward understanding pathogen ecology and transmission as well as pathogen biology. The process involves removal of unwanted fast-growing bacteria using 5% oxalic acid, inoculation on Lowenstein-Jensen medium supplemented with glycerol, and incubation at temperatures between 30 °C and 33 °C., (© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
49. The Relevance of Genomic Epidemiology for Control of Tuberculosis in West Africa.
- Author
-
Asare P, Asante-Poku A, Osei-Wusu S, Otchere ID, and Yeboah-Manu D
- Subjects
- Africa, Western epidemiology, Genomics, Humans, Mycobacterium tuberculosis genetics, Tuberculosis diagnosis, Tuberculosis, Multidrug-Resistant drug therapy
- Abstract
Tuberculosis (TB), an airborne infectious disease caused by Mycobacterium tuberculosis complex (MTBC), remains a global health problem. West Africa has a unique epidemiology of TB that is characterized by medium- to high-prevalence. Moreover, the geographical restriction of M. africanum to the sub-region makes West Africa have an extra burden to deal with a two-in-one pathogen. The region is also burdened with low case detection, late reporting, poor treatment adherence leading to development of drug resistance and relapse. Sporadic studies conducted within the subregion report higher burden of drug resistant TB (DRTB) than previously thought. The need for more sensitive and robust tools for routine surveillance as well as to understand the mechanisms of DRTB and transmission dynamics for the design of effective control tools, cannot be overemphasized. The advancement in molecular biology tools including traditional fingerprinting and next generation sequencing (NGS) technologies offer reliable tools for genomic epidemiology. Genomic epidemiology provides in-depth insight of the nature of pathogens, circulating strains and their spread as well as prompt detection of the emergence of new strains. It also offers the opportunity to monitor treatment and evaluate interventions. Furthermore, genomic epidemiology can be used to understand potential emergence and spread of drug resistant strains and resistance mechanisms allowing the design of simple but rapid tools. In this review, we will describe the local epidemiology of MTBC, highlight past and current investigations toward understanding their biology and spread as well as discuss the relevance of genomic epidemiology studies to TB control in West Africa., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Asare, Asante-Poku, Osei-Wusu, Otchere and Yeboah-Manu.)
- Published
- 2021
- Full Text
- View/download PDF
50. Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history.
- Author
-
Coscolla M, Gagneux S, Menardo F, Loiseau C, Ruiz-Rodriguez P, Borrell S, Otchere ID, Asante-Poku A, Asare P, Sánchez-Busó L, Gehre F, Sanoussi CN, Antonio M, Affolabi D, Fyfe J, Beckert P, Niemann S, Alabi AS, Grobusch MP, Kobbe R, Parkhill J, Beisel C, Fenner L, Böttger EC, Meehan CJ, Harris SR, de Jong BC, Yeboah-Manu D, and Brites D
- Subjects
- Africa, Eastern, Africa, Western, Evolution, Molecular, Genome, Bacterial, High-Throughput Nucleotide Sequencing, Humans, Mycobacterium tuberculosis genetics, Mycobacterium tuberculosis isolation & purification, Phylogeny, Phylogeography, Drug Resistance, Bacterial, Mycobacterium tuberculosis classification, Tuberculosis microbiology, Whole Genome Sequencing methods
- Abstract
Human tuberculosis (TB) is caused by members of the Mycobacterium tuberculosis complex (MTBC). The MTBC comprises several human-adapted lineages known as M. tuberculosis sensu stricto , as well as two lineages (L5 and L6) traditionally referred to as Mycobacterium africanum . Strains of L5 and L6 are largely limited to West Africa for reasons unknown, and little is known of their genomic diversity, phylogeography and evolution. Here, we analysed the genomes of 350 L5 and 320 L6 strains, isolated from patients from 21 African countries, plus 5 related genomes that had not been classified into any of the known MTBC lineages. Our population genomic and phylogeographical analyses showed that the unclassified genomes belonged to a new group that we propose to name MTBC lineage 9 (L9). While the most likely ancestral distribution of L9 was predicted to be East Africa, the most likely ancestral distribution for both L5 and L6 was the Eastern part of West Africa. Moreover, we found important differences between L5 and L6 strains with respect to their phylogeographical substructure and genetic diversity. Finally, we could not confirm the previous association of drug-resistance markers with lineage and sublineages. Instead, our results indicate that the association of drug resistance with lineage is most likely driven by sample bias or geography. In conclusion, our study sheds new light onto the genomic diversity and evolutionary history of M. africanum , and highlights the need to consider the particularities of each MTBC lineage for understanding the ecology and epidemiology of TB in Africa and globally.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.